# Disrupt PAD+ Study With the Shockwave Medical M5+ Peripheral IVL System

> **NCT04585763** · NA · COMPLETED · sponsor: **Shockwave Medical, Inc.** · enrollment: 37 (actual)

## Conditions studied

- Peripheral Arterial Disease
- Vascular Disease, Peripheral

## Interventions

- **DEVICE:** Shockwave Medical M5+ Peripheral Intravascular Lithotripsy (IVL)

## Key facts

- **NCT ID:** NCT04585763
- **Lead sponsor:** Shockwave Medical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-16
- **Primary completion:** 2021-08-25
- **Final completion:** 2022-11-21
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2024-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04585763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04585763, "Disrupt PAD+ Study With the Shockwave Medical M5+ Peripheral IVL System". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT04585763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*